Lung squamous cell carcinoma If you understand medicine, please enter, the difference and harm betwe

15 grams of ginseng, 30 grams of astragalus, 15 grams of angelica, 15 grams of skullcap, 15 grams of banxia, 20 grams of cistanche, 20 grams of zhimu.

Poria cocos 15 grams, Atractylodes macrocephalus 15 grams, Asparagus 15 grams, ochre 30 grams, almond 15 grams, Aster 15 grams, tangerine peel 15 grams, coltsfoot 15 grams, Zhu Ling 15 grams, melon 15 grams, Baibu 15 grams, Panax notoginseng 15 grams, licorice 20 grams, Houttuynia cordata 30 grams.

30 grams of half-branched lotus, 30 grams of white-flowered snaketongue, 30 grams of safflower seeds, 20 grams of yellow herbs, 15 grams of Chuanxiong, 30 grams of beef roots, 15 grams of fritillary, 20 grams of pangolins, 15 grams of constipation and rhubarb. The medicine is crushed into the end, twice in the morning and evening, 5 grams each time, and 15 grams of cow root grass decoction is used.

It can promote the development of traditional Chinese medicine, and various cancer prescriptions will be announced in the future.

Friends from all walks of life criticized and corrected.

Postoperative chemotherapy has a great impact on the long-term survival rate after surgery, and the application must be emphasized, and the application of chemotherapy is generally in favor of 4 6 cycles, if chemotherapy is effective, it is estimated that the operation cannot be removed cleanly, and the lesions found during the operation cannot be completely removed, and regional radiation should be given**.

Chemotherapy kills cancer cells in the blood of the whole body, and a whole body bone scan is done to see if the bones are colored, b, to see the liver, gallbladder, kidney, CT, heart, lung, head, CT, to see the cancer content in the brain, biochemistry, and blood.

Since we want to talk about lung adenocarcinoma and squamous cell carcinoma, let's talk about the classification of lung cancer!

Lung cancer is divided into small cell carcinoma and non-small cell carcinoma.

1) Small cell carcinoma develops rapidly, generally hematogenous metastasis, so the speed of metastasis is also fast, but if small cell carcinoma is detected early, this type is the most sensitive to chemotherapy, and the ** rate is also very high, but if it is advanced, the survival time is the shortest, about 3-6 months.

2) Non-small cell carcinoma is divided into: glandular squamous glandular squamous (other composite types), in non-small cell carcinoma is relatively light is squamous type, the common people's words are that the toxicity of this type is relatively small, and the toxicity of glandular type is greater than that of squamous type, and there is distant metastasis, glandular type metastasis is faster than squamous type, because squamous type is the first lymphatic metastasis, and glandular type is mostly hematogenous metastasis, which is prone to distant metastasis such as: liver, bone, brain metastasis.

Both NSCLCs are less sensitive to chemotherapy than small cells.

The two clinical symptoms of adenocarcinoma are faster and more toxic, and if it is advanced, it is necessary to consider whether there is metastasis, and there is also the level of differentiation, the lower the differentiation, the greater the toxicity!

Squamous cell carcinoma of the lung and adenocarcinoma of the lung are both lung cancers, because they have different names because they occur in different parts of the body, squamous cell carcinoma of the lung that occurs above the bronchial tube, and adenocarcinoma of the lung that occurs below the bronchi. Both diseases are more sensitive to chemotherapy, but the prognosis of lung adenocarcinoma is worse. No matter what kind of lung cancer it is, it must be found in time to prolong life.

Adenocarcinoma of the lung and squamous cell carcinoma of the lung are different pathological types of lung cancer, adenocarcinoma is generally cyclical, mostly blood metastasis, squamous cell carcinoma is more central, lymphatic metastasis is more common. Both can have moderate-to-high and low-differentiation, high or low malignancy, and are moderately sensitive to chemoradiotherapy.

Lung adenocarcinoma is a type of lung cancer, which is divided into small cell lung cancer and non-small cell lung cancer, non-small cell is divided into lung squamous cell carcinoma and lung adenocarcinoma, and lung cancer is divided into central lung cancer and peripheral lung cancer according to the location. More non-small cell lung cancer and lung adenocarcinoma are more common in women in non-smokers, so more lung adenocarcinoma is in female non-smokers, especially with CT screening and health examination, this small intrapulmonary nodule can be found to be more common in female non-smokers.

The main difference between lung adenocarcinoma and lung squamous cell carcinoma is that they have different degrees of lesions.

The biggest difference between adenocarcinoma and squamous cell carcinoma of the lungs is that the cancer cells grow at different locations. It is very easy to judge that squamous cell carcinoma of the lung occurs above the bronchial tube, and adenocarcinoma of the lung that develops below the bronchial tube. The prognosis of lung adenocarcinoma may not be as good as that of lung squamous cell carcinoma, both of which are more sensitive to chemotherapy.

If it is carcinoma in situ and stage I, neither of them is serious, and there is a chance of surgery**. In the middle and late stages, both types are more severe. Lung adenocarcinoma and lung squamous cell carcinoma have different pathological types, and the way tumor cells grow is very different.

It is easy to cause airway obstruction, obstructive pneumonia and atelectasis, invasion of large blood vessels, and easy to cause blood in sputum and hemoptysis. Therefore, patients with squamous cell carcinoma of the lung have a higher incidence of hemoptysis than adenocarcinoma. In the case of massive hemoptysis, suffocation may occur and be life-threatening.

Squamous cell carcinoma and adenocarcinoma of the lungs are the most common types of lung cancer. Both are malignant tumors, and if they are early-stage tumors, they can be **, and if they are advanced, they can't**. Therefore, it is unscientific and unrigorous to talk about which is more serious regardless of the stage of cancer.

Targeting**: This refers mainly to lung adenocarcinoma, which has little to do with squamous cell carcinoma. The targeting** of lung cancer is aimed at driver gene mutations, that is, EGFR and ALK gene mutations, which is the biggest advantage of lung adenocarcinoma** over lung squamous cell carcinoma.

In the past 50 years, many countries have reported a significant increase in the incidence and mortality of lung cancer, with the incidence and mortality of lung cancer in men accounting for the first place among all malignant tumors, the incidence of lung cancer in women accounting for the second place, and the mortality rate accounting for the second place. Most of the diagnosis can be made by histopathological examination, and immunohistochemistry is required if the diagnosis is not confirmed. Lung adenocarcinoma and lung squamous cell carcinoma are both ** tissue epithelial cells, as the name suggests, one is glandular epithelium and the other is squamous epithelium, both belong to non-small cell lung cancer.

In fact, in clinical practice, there is no single indicator that can clearly explain which is more serious, lung adenocarcinoma and lung squamous cell carcinoma, because it is only two artificial names, and it should be judged according to the actual situation. Lung cancer is currently the malignant tumor with the highest incidence, and lung cancer is divided into non-small cell lung cancer and small cell lung cancer, with non-small cell lung cancer accounting for 80% and small cell lung cancer accounting for 20%. These symptoms are not obvious, so they are ignored at an early stage.

As the disease progresses, it will appear at a later stage. Coughing up blood and other symptoms.

In fact, both cancers are very serious, and if you have to compare them with one another, it must be lung adenocarcinoma that is more serious, the onset is fast, and it is very difficult.

Squamous cell carcinoma is more serious, my old man is squamous cell carcinoma develops fast, there is no specific drug, chemotherapy drugs and targeted drugs are not good for squamous cell carcinoma, but adenocarcinoma is better, and now many targeted drugs have a good effect on adenocarcinoma.

Squamous cell carcinoma of the lungs is more serious because the disease has reached the point where it cannot be treated, and it can only be controlled by drinking medicine, so that life can be prolonged.

I think both of these are quite serious. I think that as long as it is cancer, it is not a minor disease, so we must pay attention to protect our body in our daily life.

The key is to look at the physique, everyone pays too much attention to the disease itself, and the physique is the most important.

You'll have to do both, so you'll find out for yourself!

It's all easy to control, mainly the prescription that is opened,

Can you stop talking about smoking all the time?

My fourth uncle is squamous cell carcinoma of the lung, and I am studying medicine myself, so I have been paying attention to the progress of this disease. The fourth uncle has been using camrelizumab, and I only knew that this is one of the domestic PD-1 monoclonal antibodies with the largest number of approved indications in our country, and it has been included in the medical insurance. Therefore, it can be said that it has always been the doctor's ** program and the country's policy that have given us basic trust in camrelizumab, and of course its ** effect is indeed very good.

I would like to say that the data released at the European Conference on Lung Cancer in March this year gave me a deep understanding of camrelizumab! Professor Zhou Caicun from Shanghai Pulmonary Hospital affiliated to Tongji University made an oral report at the conference, mentioning that the median survival of camrelizumab combined with chemotherapy group was nearly one year longer than that of the chemotherapy group, setting the highest median survival record in similar studies. This is definitely exciting news for squamous cell lung carcinoma (SCC), because it means that patients have taken a big step towards 5-year survival, and with this progress, the future of lung squamous cell carcinoma** is no longer so far away

Peripheral lung cancer squamous cell carcinoma, although the patient was diagnosed with advanced lung cancer (stage 3a) in the hospital, but from the examination results, the condition is not serious, although there is metastasis, but only lymphatic metastasis, bone, brain, liver and other major organs have not been found metastasis, and the body is not accompanied by other serious diseases, as long as the physique is good, the hope should still be relatively large.

It is recommended that the patient combine internal medicine and surgery**, if the operation can be performed, surgery can be considered first (note: "surgery" does not belong to Western medicine, Chinese medicine also pays attention to surgery, thousands of years ago Hua Tuo is the representative of traditional Chinese medicine surgery, surgery belongs to surgery), after surgery internal medicine ** (Chinese medicine **) can also consider the combination of traditional Chinese and Western medicine, but lung squamous cell carcinoma is not very sensitive to chemotherapy, Western medicine chemotherapy may not be very effective, in terms of traditional Chinese medicine, you can consider traditional Chinese medicine internal administration, acupoint application (external use), anti-cancer drug foot soaking, Dietary therapy and other comprehensive**.

Traditional Chinese medicine + Western medicine + Buddhist medicine + Taoist medicine, all-round comprehensive treatment is safer and more hopeful.

Squamous cell carcinoma of the lung, also known as squamous cell carcinoma of the lung, includes spindle cell carcinoma, and is the most common type, accounting for 40% to 51% of primary lung cancers. Squamous cell carcinoma of the lung is more common in older men and is closely related to smoking. Lung squamous cell carcinoma is more common as type ** lung cancer, and has a tendency to grow in the chest lumen, and lung squamous cell carcinoma often causes bronchial stenosis or obstructive pneumonia in the early stage.

Lung squamous cell carcinoma grows slowly, metastasizes late, has more opportunities for surgical resection, has a higher 5-year survival rate, and lung squamous cell carcinoma is less sensitive to radiotherapy and chemotherapy than small cell undifferentiated carcinoma.